ID

40702

Descrizione

Busulfan, Cyclophosphamide, and Melphalan or Busulfan and Fludarabine Phosphate Before Donor Hematopoietic Cell Transplant in Treating Younger Patients With Juvenile Myelomonocytic Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT01824693

collegamento

https://clinicaltrials.gov/show/NCT01824693

Keywords

versioni (1)
  1. 30/04/20 30/04/20 -
Titolare del copyright

See clinicaltrials.gov

Caricato su

30 aprile 2020

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Juvenile Myelomonocytic Leukemia NCT01824693

Inglese

Eligibility Juvenile Myelomonocytic Leukemia NCT01824693

1 moduli  
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients must have a strong clinical suspicion of jmml, based on a modified category 1 of the revised diagnostic criteria; specifically, eligible patients must have all of the following:
Descrizione

Suspicion Juvenile Myelomonocytic Leukemia

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0242114
UMLS CUI [1,2]
C0349639
splenomegaly
Descrizione

Splenomegaly

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0038002
absolute monocyte count (amc) > 1000/ul
Descrizione

Monocyte count procedure

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0200637
blasts in peripheral blood (pb)/bone marrow (bm) < 20%
Descrizione

Blasts Peripheral blood Percentage | Blasts Bone Marrow Percentage

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0368761
UMLS CUI [1,2]
C0229664
UMLS CUI [1,3]
C0439165
UMLS CUI [2,1]
C0368761
UMLS CUI [2,2]
C0005953
UMLS CUI [2,3]
C0439165
for the 7-10% of patients without splenomegaly, the diagnostic entry criteria must include all other features described above and at least 2 of the following criteria:
Descrizione

Patients Without Splenomegaly | Diagnostic criteria Fulfill

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C0332288
UMLS CUI [1,3]
C0038002
UMLS CUI [2,1]
C0679228
UMLS CUI [2,2]
C1550543
circulating myeloid precursors
Descrizione

Myeloid precursor cell Circulating

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1268007
UMLS CUI [1,2]
C0175630
white blood cell (wbc) > 10,000/ul
Descrizione

White Blood Cell Count procedure

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0023508
increased fetal hemoglobin (hgbf) for age
Descrizione

Elevated fetal hemoglobin | Relationship Age

Tipo di dati

boolean

Alias
UMLS CUI [1]
C2751485
UMLS CUI [2,1]
C0439849
UMLS CUI [2,2]
C0001779
sargramostim (gm-csf) hypersensitivity or, patients must have been previously diagnosed with jmml
Descrizione

Hypersensitivity Sargramostim | Prior diagnosis Juvenile Myelomonocytic Leukemia

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0216231
UMLS CUI [2,1]
C0332132
UMLS CUI [2,2]
C0349639
patients must be previously untreated with hct
Descrizione

Hemopoietic stem cell transplant Absent

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0472699
UMLS CUI [1,2]
C0332197
all patients and/or their parents or legal guardians must sign a written informed consent
Descrizione

Informed Consent | Informed Consent Parent | Informed Consent Legal Guardians

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0021430
UMLS CUI [2,1]
C0021430
UMLS CUI [2,2]
C0030551
UMLS CUI [3,1]
C0021430
UMLS CUI [3,2]
C0023226
all institutional, food and drug administration (fda), and national cancer institute (nci) requirements for human studies must be met
Descrizione

Requirement Human studies Fulfill

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1514873
UMLS CUI [1,2]
C0178693
UMLS CUI [1,3]
C1550543
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients with a known germline mutation of ptpn11 (noonan's syndrome) are not eligible
Descrizione

Germ-Line Mutation PTPN11 | Noonan Syndrome

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0206530
UMLS CUI [1,2]
C1335280
UMLS CUI [2]
C0028326
patients with a known history of nf1 (neurofibromatosis type 1) and either
Descrizione

Neurofibromatosis Type

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0162678
UMLS CUI [1,2]
C0332307
a history of a tumor of the central nervous system (astrocytoma or optic glioma), or
Descrizione

Central Nervous System Neoplasms | Astrocytoma | Optic Nerve Glioma

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0085136
UMLS CUI [2]
C0004114
UMLS CUI [3]
C0346326
a malignant peripheral nerve sheath tumor with a complete remission of < 1 year are not eligible
Descrizione

Malignant Peripheral Nerve Sheath Tumor Complete remission Duration

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0751690
UMLS CUI [1,2]
C0677874
UMLS CUI [1,3]
C0449238
human immunodeficiency virus (hiv) positive patients are not eligible
Descrizione

HIV Seropositivity

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0019699
Ritorna all'inizio della pagina

Similar models

Eligibility Juvenile Myelomonocytic Leukemia NCT01824693

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
Suspicion Juvenile Myelomonocytic Leukemia
Item
patients must have a strong clinical suspicion of jmml, based on a modified category 1 of the revised diagnostic criteria; specifically, eligible patients must have all of the following:
boolean
C0242114 (UMLS CUI [1,1])
C0349639 (UMLS CUI [1,2])
Splenomegaly
Item
splenomegaly
boolean
C0038002 (UMLS CUI [1])
Monocyte count procedure
Item
absolute monocyte count (amc) > 1000/ul
boolean
C0200637 (UMLS CUI [1])
Blasts Peripheral blood Percentage | Blasts Bone Marrow Percentage
Item
blasts in peripheral blood (pb)/bone marrow (bm) < 20%
boolean
C0368761 (UMLS CUI [1,1])
C0229664 (UMLS CUI [1,2])
C0439165 (UMLS CUI [1,3])
C0368761 (UMLS CUI [2,1])
C0005953 (UMLS CUI [2,2])
C0439165 (UMLS CUI [2,3])
Patients Without Splenomegaly | Diagnostic criteria Fulfill
Item
for the 7-10% of patients without splenomegaly, the diagnostic entry criteria must include all other features described above and at least 2 of the following criteria:
boolean
C0030705 (UMLS CUI [1,1])
C0332288 (UMLS CUI [1,2])
C0038002 (UMLS CUI [1,3])
C0679228 (UMLS CUI [2,1])
C1550543 (UMLS CUI [2,2])
Myeloid precursor cell Circulating
Item
circulating myeloid precursors
boolean
C1268007 (UMLS CUI [1,1])
C0175630 (UMLS CUI [1,2])
White Blood Cell Count procedure
Item
white blood cell (wbc) > 10,000/ul
boolean
C0023508 (UMLS CUI [1])
Elevated fetal hemoglobin | Relationship Age
Item
increased fetal hemoglobin (hgbf) for age
boolean
C2751485 (UMLS CUI [1])
C0439849 (UMLS CUI [2,1])
C0001779 (UMLS CUI [2,2])
Hypersensitivity Sargramostim | Prior diagnosis Juvenile Myelomonocytic Leukemia
Item
sargramostim (gm-csf) hypersensitivity or, patients must have been previously diagnosed with jmml
boolean
C0020517 (UMLS CUI [1,1])
C0216231 (UMLS CUI [1,2])
C0332132 (UMLS CUI [2,1])
C0349639 (UMLS CUI [2,2])
Hemopoietic stem cell transplant Absent
Item
patients must be previously untreated with hct
boolean
C0472699 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
Informed Consent | Informed Consent Parent | Informed Consent Legal Guardians
Item
all patients and/or their parents or legal guardians must sign a written informed consent
boolean
C0021430 (UMLS CUI [1])
C0021430 (UMLS CUI [2,1])
C0030551 (UMLS CUI [2,2])
C0021430 (UMLS CUI [3,1])
C0023226 (UMLS CUI [3,2])
Requirement Human studies Fulfill
Item
all institutional, food and drug administration (fda), and national cancer institute (nci) requirements for human studies must be met
boolean
C1514873 (UMLS CUI [1,1])
C0178693 (UMLS CUI [1,2])
C1550543 (UMLS CUI [1,3])
Item Group
C0680251 (UMLS CUI)
Germ-Line Mutation PTPN11 | Noonan Syndrome
Item
patients with a known germline mutation of ptpn11 (noonan's syndrome) are not eligible
boolean
C0206530 (UMLS CUI [1,1])
C1335280 (UMLS CUI [1,2])
C0028326 (UMLS CUI [2])
Neurofibromatosis Type
Item
patients with a known history of nf1 (neurofibromatosis type 1) and either
boolean
C0162678 (UMLS CUI [1,1])
C0332307 (UMLS CUI [1,2])
Central Nervous System Neoplasms | Astrocytoma | Optic Nerve Glioma
Item
a history of a tumor of the central nervous system (astrocytoma or optic glioma), or
boolean
C0085136 (UMLS CUI [1])
C0004114 (UMLS CUI [2])
C0346326 (UMLS CUI [3])
Malignant Peripheral Nerve Sheath Tumor Complete remission Duration
Item
a malignant peripheral nerve sheath tumor with a complete remission of < 1 year are not eligible
boolean
C0751690 (UMLS CUI [1,1])
C0677874 (UMLS CUI [1,2])
C0449238 (UMLS CUI [1,3])
HIV Seropositivity
Item
human immunodeficiency virus (hiv) positive patients are not eligible
boolean
C0019699 (UMLS CUI [1])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial